Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 4.640 | 5.360 | 0.720 |
Stocks | 95.370 | 95.370 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.615 | 19.916 |
Price to Book | 2.391 | 2.733 |
Price to Sales | 1.455 | 1.824 |
Price to Cash Flow | 10.898 | 13.676 |
Dividend Yield | 1.322 | 1.834 |
5 Years Earnings Growth | 11.037 | 12.468 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 37.180 | 14.178 |
Industrials | 22.270 | 37.166 |
Technology | 11.770 | 14.344 |
Consumer Defensive | 9.520 | 5.574 |
Real Estate | 8.140 | 11.518 |
Communication Services | 6.170 | 5.163 |
Basic Materials | 1.820 | 4.874 |
Financial Services | 1.750 | 5.935 |
Consumer Cyclical | 1.380 | 7.606 |
Number of long holdings: 37
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AAK | SE0011337708 | 6.33 | 319.0 | -0.37% | |
Ambea | SE0009663826 | 6.07 | 98.35 | +1.13% | |
MedCap | SE0009160872 | 5.52 | 614.000 | -0.16% | |
Vimian Group AB | SE0015961982 | 4.51 | 40.25 | +0.12% | |
Lagercrantz B | SE0014990966 | 4.48 | 209.40 | -0.38% | |
Fastighets AB Balder B | SE0017832488 | 4.45 | 77.00 | +0.05% | |
Addtech | SE0014781795 | 4.32 | 304.40 | 0.00% | |
Bufab Holding AB | SE0005677135 | 4.26 | 439.80 | +0.18% | |
Xvivo Perfusion AB | SE0004840718 | 3.96 | 505.00 | -1.56% | |
Tobii Dynavox AB | SE0017105620 | 3.91 | 62.40 | -1.89% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Evli Global B SEK | 3.19B | 16.84 | 13.87 | 12.97 | ||
Evli Sweden Equity Index B | 2.71B | 7.59 | 6.46 | 8.58 | ||
Evli Swedish Small Cap B | 1.5B | 5.84 | -9.86 | 12.55 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review